PhD Graduates and Post-Doc Researchers
Want to help people do more, feel better and live longer?
GlaxoSmithKline (GSK) is a global healthcare company with a special purpose of helping people to do more, feel better and live longer. We employ 100,000 people in over 115 countries who work across our Pharmaceuticals, Vaccines and Consumer Healthcare businesses.
We are seeking PhD graduates and postdoc researchers to join the GSK PhD Graduate Innovation Program (GPGIP) in March 2021. We have exciting opportunities for paid 12-month, fixed-term contracts based in Abbotsford (VIC).
The GSK PhD Graduate Innovation Program:
The GSK PhD Graduate Innovation Program is a government-funded, industry-hosted initiative developed to help bridge the gap between industry and research.
The paid 12-month work placement program is available to PhD graduates or post doc researchers. The aim of the program is to provide interns with a diverse range of development opportunities, experiences and exposure with view to improving Australia’s success in terms of translation and commercialisation of health and medical research; and expanding the capacity and capability.
At GSK, we’re excited to embark on this program with the support of MTPConnect. We are driven by science, curiosity and a desire to transform the lives of our patients. The roles we have identified to form our 2021 GSK PhD Graduate Innovation Program will lead on important, substantive work. We anticipate that the 2021 PhDs joining our business will bring critical thinking and creativity into our business, while at the same time, we’re committed to offering these individuals hands on insights and training in the corporate environment and the work we do to bring our scientific discoveries into patients’ hands.
- Must be a PhD graduate or postdoc researcher
- Must be a citizen or permanent resident of Australia or New Zealand.
- Must be available to work full-time from March 2021 to March 2022.
What roles are available?
- Oncology Medical Affairs
- ViiV Healthcare (HIV)
- Regulatory Affairs
- Vaccines (Meningococcal Disease)
- Specialty Care
- Vaccines Medical Education & Delivery Excellence
What is it like?
To see the 2021 GSK PhD Graduate Innovation Program Project Descriptions, click on the roles in the section above (A Word document will download when the link is clicked).
What does the application process involve?
- Eligibility Questionnaire
- World of GSK online assessment (This assessment must be completed before applications close on Wednesday 2 December, any assessments completed after applications close will not be viewed)
- Pre-Recorded Video Assessment
- Final Interview (Virtual): Activity & Interview
Where can I apply?
Applications for the 2021 intake have now closed. Applications for the 2022 intake will open in October/November 2021.
Need help with your application?
Please email us at ANZ.Careers@gsk.com and let us know how we can help you. We will make all reasonable modifications to support you throughout the recruitment process and we’ll treat all information you give us in confidence. Please get in touch to help us process your application as soon as possible.
At GSK we believe in the power of an inclusive and diverse workforce. We aim to create an inclusive workplace where all employees feel engaged, supported and know that their work makes an important contribution. We are an equal opportunity employer and all applicants will be considered regardless of sexuality, religion, colour, ethnicity, gender identity or parental status.
GSK Australia today welcomed the addition of Meningococcal B (MenB) vaccination for Aboriginal and Torres Strait Islander infants to the National Immunisation Program (NIP)1 as well as people of all ages with some medical conditions that increase their risk of Invasive Meningococcal Disease (IMD).